Fundraising FoxNextera
1 known investors
Find your way into Nextera
Sign up to see every warm intro you have to Nextera
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Nextera team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Nextera develops TCR-Like antibody drug candidates that target disease-specific pHLA antigens for cancer, autoimmune, and inflammatory diseases. It uses protein engineering and phage display technology to build targeted immunotherapies aimed at intracellular disease antigens.
Investors · 1
Frequently asked questions
- What does Nextera do?
- Nextera develops TCR-Like antibody drug candidates that target disease-specific pHLA antigens for cancer, autoimmune, and inflammatory diseases. It uses protein engineering and phage display technology to build targeted immunotherapies aimed at intracellular disease antigens.
- Who are Nextera's investors?
- Nextera's investors include Birk Venture.